Find therapies in clinical trials near you – page 732

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

Study on Olaparib for Patients with Advanced HER2-Negative Breast Cancer and Specific Genetic Mutations

Study on Olaparib for Patients with Advanced HER2-Negative Breast Cancer and Specific Genetic Mutations

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Study on the Safety and Effectiveness of SRP-9003 and Prednisone for Patients with Limb-Girdle Muscular Dystrophy Type 2E/R4

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Study on the Effects of Acalabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Study on the Safety and Immune Response of RSVPreF3 Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Above